Venbio Partners

Venture Capital Exempt reporting adviser

Legal name: Venbio Partners LLC

San Francisco, CA Website LinkedIn

AUM

$1.8B
Private fund assets

Private funds

5
Venture Capital 5

Private fund assets

$1.8B
Gross asset value

Employees

—

Last Form D raise

Jul 2024
Most recent fund filing

From SEC Form ADV filing (filed Mar 12, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

A
Aaron Royston
Managing Director
Source: SEC Form ADV
C
Corey Goodman
Managing Director
Source: SEC Form ADV
R
Richard Gaster
Managing Director
Source: SEC Form ADV

Funds(5)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Venbio Global Strategic Fund V, L.P.Venture Capital$528.1M$504.7M162Jul 2024Cold
Venbio Global Strategic Fund IV, L.P.Venture Capital$549.9M$549.9M147May 2021Cold
Venbio Global Strategic Fund III, LPVenture Capital$393.5M$386.1M100Mar 2020Cold
Venbio Global Strategic Fund II, L.P.Venture Capital$340.4M$337.0M31Mar 2017Cold
Venbio Global Strategic Fund, L.P.Venture Capital$1.8M———

Board seats(2)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Insamo
BiotechnologyBerkeley, CADirector: Corey Goodman
$11.8M raised
Since Mar 2023
SEC Form D
Solstice Biologics
PharmaceuticalsSan Francisco, CADirector: Corey Goodman
$11.5M raised
Since Oct 2014
SEC Form D

Regulatory identifiers

CRD number
290045
SEC file number
802-111956

Sources